AARC Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients Guideline Summary - Guideline Central
Recommendations
Document Overview

Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients

American Association for Respiratory Care


Publication Date: Dec 1, 2015

Page Last Updated: May 5, 2026



Document Overview

Document Title
Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients
Authoring Society

American Association for Respiratory Care

Document Publication Date
Dec 1, 2015
Page Last Reviewed/Updated
May 5, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
www.aarc.org/wp-content/uploads/2014/08/pharm_cpg.pdf
Source Citation

Respir Care 2015;60(7):1071–1077


Supplemental Implementation Resources


Document Scope, Criteria, and Use Cases

Document Objectives
The purpose of this guideline is to provide guidance to clinicians in the identification, selection, and delivery of medication for airway clearance. This guideline does not include the use of medication for patients with cystic fibrosis, as this has been addressed.
Scope
Assessment and Screening, Management, Treatment
Diseases/Conditions (MeSH)

D006493 - Heparin

D058109 - Airway Management

D020545 - Respiratory Mucosa

D006493 - Heparin

D058109 - Airway Management

D020545 - Respiratory Mucosa

Keywords
airway management, airway restriction, difficult airway, mucolytics
Target Patient Population
Patients require airway clearance therapy
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older Adult
Health Care Settings
Emergency Care, Hospital
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Number of Source Documents
8
Literature Search End Date
Tuesday, June 30, 2015
Includes peer/external review process?
Yes
Includes public comment process?
No
Methodologist involvement?
Yes
Patient involvement?
No
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
Yes
Grades quality of strength of recommendation?
No
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
Yes
Identifies study selection process?
Yes
Identifies study selection criteria?
Yes
Identifies methods used to evaluate and analyze the evidence?
Yes
Identifies key questions addressed by the systematic review?
Yes
Identifies search strategy?
Yes
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.